Navigation Links
ADVANCE Posterior Stabilized Total Knee Systems

ProductsADVANCE Posterior Stabilized Total Knee Systems
Company Wright Medical Technology, Inc.
Item ADVANCE Posterior Stabilized Total Knee Systems
Features All-Poly Patellar Components are offered in both single and tri-peg configurations. Patellar components are completely interchangeable with any size femoral component, improving the flexibility required to match patient anatomy and available bone with implant size. Both designs incorporate cement interlock features. The tri-peg design maintains a constant peg pattern easing intraoperative size changes.
Description The major innovations in posterior stabilized (PS) knee design.
Info Wright Medical Technology, Inc.
Customer Service: (800) 238-7117
Web site: http://www.wmt.com/

Related medicine products :

1. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
2. SureCut M3500 Radial Microtome-ADVANCED
3. PRIMEADVANCED Neurostimulator
4. RESTOREADVANCED Neurostimulator
5. Holladay Posterior Capsule Polisher and Curette
6. Posterior Capsule Polisher, 23 g
7. Posterior Capsule Polisher, 21 g
8. Simcoe Posterior Chamber Lens Forceps
9. Spine-Tract Posterior Lumbar Retractor System
10. Image-Trac Posterior Spine Retractor System
11. Graftech Posterior Ramp
Breaking Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 1Sysmex Supports Illinois Chapter Leukemia and Lymphoma Society 52505 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 1President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 3St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 1St Johns Hospital Acquires Latest Technology in Robotic Assisted Surgery 13163 2